跳转至内容
Merck
CN
所有图片(1)

文件

OP44

Sigma-Aldrich

APC (Ab-1)小鼠单克隆抗体(FE9)

liquid, clone FE9, Calbiochem®

登录查看公司和协议定价

别名:
抗-腺瘤性息肉病性大肠埃希菌
UNSPSC代码:
12352203
NACRES:
NA.43

生物来源

mouse

质量水平

抗体形式

purified antibody

抗体产品类型

primary antibodies

克隆

FE9, monoclonal

形式

liquid

包含

≤0.1% sodium azide as preservative

种属反应性

rat, human, mouse

制造商/商品名称

Calbiochem®

储存条件

do not freeze

同位素/亚型

IgG1

运输

wet ice

储存温度

2-8°C

靶向翻译后修饰

unmodified

基因信息

human ... APC(324)

一般描述

可识别HCT116细胞中的全长APC(p300)和SW480细胞中的截短APC(p147)。
  • 抗体靶基因符号:APC
  • 目标同义词:AI047805,Apc7,AU020952,AW124434,BTPS2,DP2,DP2.5,DP3,家族性腺瘤性息肉病,FAP,GS,Min,RATAPC
  • Entrez基因名称:腺瘤性息肉病
  • Hu Entrez ID:324(有关抗体:OP80ST1150OP62OP47L
  • Mu Entrez ID:11789
  • 大鼠Entrez ID:24205
  • 抗APC(Ab-1),小鼠单克隆,克隆FE9,可识别HCT116细胞中的全长APC(p300)和SW480细胞中的截短APC(p147)。它已被验证可用于蛋白质印迹法。
    蛋白G纯化小鼠单克隆抗体是通过用指定的免疫原免疫小鼠并将脾细胞与SP40细胞融合而产生的。可识别~300 kDa APC蛋白以及多种截短形式。

    免疫原

    一种与APC N端35个氨基酸对应的合成肽

    应用

    免疫印迹(1 µg/ml,参见注释)

    包装

    请参考特定浓度批号的标签。

    警告

    毒性:标准处理(A)

    外形

    溶于50 mM磷酸钠缓冲液(pH 7.5),含0.2%明胶。

    分析说明

    阳性对照
    HCT116细胞用于p300,SW480细胞用于截短APC(p147)

    其他说明

    Koetsier, P. A., et al. 1993.BioTechniques15, 258.
    Smith, K. J., et al. 1993.Proc.Natl.Acad.Sci., USA90, 2846.
    Su, L.-K., et al. 1993.Can.Res.53, 2728.
    Boynton, R. F., et al. 1992.Proc.Natl.Acad.Sci. USA89, 3385.
    D′Amico, D., et al. 1992.Cancer Res.52, 1996.
    Fearon, E. R., and Jones, P. A., 1992.FASEB J.6, 2783.
    Miyoshi, Y., et al. 1992.Proc.Natl.Acad.Sci. USA89, 4452.
    Powell, S. M., et al. 1992.Nature359, 235.
    Groden, J., et al. 1991.Cell66, 589.
    Kinzler, K. W., et al. 1991.Science253, 661.
    Nishisho, I., et al. 1991.Science253, 665.

    法律信息

    CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

    WGK

    WGK 1

    闪点(°F)

    Not applicable

    闪点(°C)

    Not applicable


    分析证书(COA)

    输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

    已有该产品?

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Mireia Menéndez et al.
    Gastroenterology, 134(1), 56-64 (2008-01-02)
    We identified the APC N1026S variant of unknown malignant potential in the adenomatous polyposis coli (APC) gene in a Spanish attenuated familial adenomatous polyposis (AFAP) family. The variant was located in the first of the 4 highly conserved 15-amino acid
    Tamar Evron et al.
    Oncogenesis, 10(9), 63-63 (2021-09-24)
    The Wnt signaling pathways play fundamental roles during both development and adult homeostasis. Aberrant activation of the canonical Wnt signal transduction pathway is involved in many diseases including cancer, and is especially implicated in the development and progression of colorectal
    Hideaki Toki et al.
    Cancer science, 104(7), 937-944 (2013-04-05)
    Mutant mouse models are indispensable tools for clarifying the functions of genes and elucidating the underlying pathogenic mechanisms of human diseases. We carried out large-scale mutagenesis using the chemical mutagen N-ethyl-N-nitrosourea. One specific aim of our mutagenesis project was to
    Claudia Gaspar et al.
    PLoS genetics, 5(7), e1000547-e1000547 (2009-07-07)
    Germline mutations in the adenomatous polyposis coli (APC) gene are responsible for familial adenomatous polyposis (FAP), an autosomal dominant hereditary predisposition to the development of multiple colorectal adenomas and of a broad spectrum of extra-intestinal tumors. Moreover, somatic APC mutations
    Nathaniel S Rial et al.
    International journal of cancer, 124(10), 2270-2280 (2009-01-29)
    Elevated deoxycholic acid (DCA), mutations in the adenomatous polyposis coli (APC) gene and chronic inflammation are associated with increased risk of colorectal cancer. APC status was manipulated to determine whether DCA mediates inflammatory molecules in normal or initiated colonic mucosa.

    我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系技术服务部门